NEW YORK, March 21, 2026 /PRNewswire/ --. Why ...NKTR) between February 26, 2025 and December 15, 2025, both dates inclusive (the "ClassPeriod"), of the important May 5, 2026 lead plaintiff deadline. So what ... What to do next ... Why Rosen Law ... A. 21% ... .
Alert. Claims Focus on Alleged Misrepresentations About REZOLVE-AA Patient Enrollment Compliance...NKTR) securities of a pending securities class action. THE CASE ... YOUR OPTIONS. You may be entitled to compensation without payment of any out-of-pocket fees.
NKTR) and certain officers ... 7980 ... The Company's lead product candidateis rezpegaldesleukin (a/k/a REZPEG or NKTR-358), a novel, first-in-class regulatory T cell stimulator for the treatment of, inter alia, alopecia areata ... Attorney advertising ... 21%.
Alert. Claims Focus on Alleged Misrepresentations About REZOLVE-AA Patient Enrollment Compliance...NKTR) securities of a pending securities class action. THE CASE ... YOUR OPTIONS. You may be entitled to compensation without payment of any out-of-pocket fees.